Mel Bridges

A deeply experienced technology & life science investor & company builder with a demonstrated track record in transitioning companies and leading them to liquidity events for shareholders, including trade sales, mergers & IPOs

Current & previous roles include: Founder, Anatara Therapeutics 2012; Founder, Parma Corporation 2006; Founder, Impedimed 1998; Founder, PANBIO 1986; Founder, Pacific Diagnostics 1977; Founder, Techlab Enterprises 1977

Current & previous Board roles include: Chairman of Genetic Technologies, Alchemia, Leaf Energy, Impedimed, Incitive, Sarantis, Genetic Solutions, Catapult Genetics, Peptech, Cooperative Research Centre for Biomarkers, Cooperative Research Centre for Diagnostics, Farmacule, Aquacarotene; Director of Campbell Brothers, Benitec, Tissue Therapies, Genera Biosystems, Diatech, Domantis, IMBcom

Awards include: Ausbiotech “Chairman’s Gold Medal” for contribution to the Australian biotech industry, Queensland “Bioneer of the Year” 2004, Ernst Young “Entrepreneur of the Year” 2002, Bulletin “Business Leader Award” 2002

Mel Bridges is the Investment Committee member & Venture Partner at BioPacific Ventures. With a background in Venture Capital, Mel Bridges has a rich history of leadership and innovation. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.